Electromed (ELMD) Q4 FY26 earnings call

Electromed delivered a record Q4 FY26, marking its 15th consecutive quarter of revenue and profit growth, driven by strong performance in its direct home care channel and strategic investments in sales force expansion. The company continues to focus on addressing the underserved bronchiectasis market through educational campaigns and expanding payer coverage, while maintaining a strong financial position with no debt and positive operating cash flow. CEO Jim Cunniff announced his planned retirement in April 2027, with a succession process underway.